Brett Tindall Memorial Lecture 2022: Associate Professor Behzad Hajarizadeh

Event date
Tuesday 15th November 2022
Event time
1:00 PM
Event address
Level 6, Wallace Wurth Building, Kensington Campus, UNSW Sydney

Location:

In-person and online event | Registrations are essential

Kirby Institute, Seminar Room
Level 6, Wallace Wurth Building, Kensington Campus, UNSW Sydney

Cost

Free

Contact for enquiries 

Rata Joseph, +61 (2) 9385 0900 or info@kirby.unsw.edu.au

Booking

https://btml22.eventbrite.com.au/

 

Join us for our special event the 11th Annual Brett Tindall Memorial Lecture.

Associate Professor Behzad Hajarizadeh is the recipient of the 2022 Brett Tindall Memorial Lecture. His lecture will focus on his extensive and world-leading research into hepatitis C treatment uptake.

Hepatitis C treatment uptake in Australia: Making a case for equitable access
The World Health Organization has set targets for eliminating hepatitis C as a public health threat by 2030, and highly curative direct-acting antivirals (DAA) are a key tool for any hepatitis C eliminate strategy. But in some settings, these curative treatments are not widely accessed, due to a number of challenges. Internationally, a key barrier is restricted access for marginalised populations such as people who inject drugs or people who are incarcerated. In his presentation, A/Prof Hajarizadeh will present the evidence that highlights and addresses some of these challenges, including the evaluation of national DAA treatment uptake and strategies to enhance DAA treatment access and uptake.

*Please note this is a hybrid seminar with registration options for in-person and online attendance. Lunch will be provided from 12pm for in-person attendees, with the seminar to follow at 1pm.

 

Associate Professor Behzad Hajarizadeh  

Associate Professor Behzad Hajarizadeh
Associate Professor, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney

Behzad Hajarizadeh is an Associate Professor and a clinical epidemiologist in the Kirby Institute, UNSW Sydney. He trained as a Medical Practitioner and has a Masters in Public Health (MPH) and PhD in Medicine (Clinical Epidemiology). His main area of expertise is viral hepatitis with more than 15 years experience as a clinician and then researcher in the field of liver diseases. His employment history includes working as a Research Fellow in La Trobe University, Melbourne and as a Senior Research Officer and Project Coordinator in the Ministry of Health and UNAIDS country office in Iran.

 

The Brett Tindall Memorial Lecture is an annual lecture awarded to an outstanding mid-career Kirby Institute researcher, based on a recently impactful body of work.

It is awarded in memory of Dr Brett Tindall, who was one of the Kirby Institute’s first researchers in the 1980s. Brett's research focused on the process of seroconversion and the body's responses to the entry of HIV. He died of AIDS in 1994. 

  Dr Brett Tindall

 

Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.